accessibility menu, dialog, popup

UserName
New Feature

You can now browse the site in English or Deutsch.

Organic Acids

Organic compounds with acidic properties, organic acids are generally weak acids incapable of complete dissociation in water. Available in a range of chemical compositions and acid strengths, they can be used for various industrial and everyday applications.
Trifluoroacetic Acid (3)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (3)

Quantity

  • (1)
  • (1)
  • (1)

Search Within Results
Keyword Search:
1 – 1 of 1 results
1

Angiotensin II Trifluoroacetic Acid Salt (Human), TRC

Molecular Formula: C50H71N13O12 . x(C 2HF3O2) Synonym: N-[1-[N-[N-[N-[N-(N2-L-α-Aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-isoleucyl]-L-histidyl]-L-prolyl]-L-phenylalanine,[Ile5]-Ang II,[Ile5]-Angiotensin II,5-L-Isoleucineangiotensin II,10: PN: US20130023475 SEQID: 17 unclaimed protein,10: PN: WO0212471 SEQID: 17 unclaimed sequence,113: PN: WO2008104000 TABLE: 4 unclaimed sequence,11: PN: US20030119021 SEQID: 10 unclaimed sequence,1272: PN: US20050069911 SEQID: 1272 unclaimed sequence,12: PN: US20090088553 SEQID: 86 unclaimed protein,12: PN: WO0239997 SEQID: 17 unclaimed sequence,134: PN: WO02098448 SEQID: 144 unclaimed sequence,134: PN: WO02098906 SEQID: 144 unclaimed sequence,13: PN: US20120071544 SEQID: 7 unclaimed sequence,14: PN: WO2004007538 SEQID: 13 claimed sequence,14: PN: WO2011020056 SEQID: 95 claimed protein,154: PN: WO2009126292 TABLE: 4 unclaimed sequence,17: PN: US6610497 SEQID: 17 unclaimed sequence,17: PN: US6884771 SEQID: 17 unclaimed sequence,31: PN: WO0198325 SEQID: 32 claimed protein,32: PN: US20060014212 SEQID: 32 unclaimed sequence,32: PN: WO0056345 SEQID: 32 claimed sequence,7: PN: JP2005291836 SEQID: 6 unclaimed protein,7: PN: US20040209344 SEQID: 2 unclaimed sequence,7: PN: WO03072059 SEQID: 8 unclaimed sequence,80: PN: US6017693 TABLE: 4 claimed sequence,83: PN: US20050009742 PAGE: 21 claimed sequence,85: PN: US20080213898 SEQID: 83 claimed sequence,873: PN: US20040180380 SEQID: 1272 unclaimed sequence,8: PN: WO2008138350 SEQID: 8 claimed sequence,8: PN: WO9958140 SEQID: 1 claimed protein,96: PN: WO2008058016 SEQID: 96 claimed protein,9: PN: WO2008005531 SEQID: 17 unclaimed sequence,9: PN: WO2008106043 TABLE: 6 claimed protein,Angiotensin 2,Angiotensin II,Angiotensin II (human),Angiotensin II (mouse),Angiotensin II [Ile5],Asp-Arg-Val-Tyr-Ile-His-Pro-Phe,Asp1-Ile5-angiotensin II,Human angiotensin II,Ileu5-angiotensin II,Isoleucyl5-angiotensin II IUPAC Name: (2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-4-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-guanidinopropyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid2,2,2-trifluoroacetic acid SMILES: O=C(O)[C@H](CC1=CC=CC=C1)NC([C@H]2N(C([C@H](CC3=CNC=N3)NC([C@H]([C@@H](C)CC)NC([C@H](CC4=CC=C(C=C4)O)NC([C@H](C(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](CC(O)=O)N)=O)=O)=O)=O)=O)=O)CCC2)=O.OC(C(F)(F)F)=O.[F,Cl,Br,I]

SMILES O=C(O)[C@H](CC1=CC=CC=C1)NC([C@H]2N(C([C@H](CC3=CNC=N3)NC([C@H]([C@@H](C)CC)NC([C@H](CC4=CC=C(C=C4)O)NC([C@H](C(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](CC(O)=O)N)=O)=O)=O)=O)=O)=O)CCC2)=O.OC(C(F)(F)F)=O.[F,Cl,Br,I]
Synonym N-[1-[N-[N-[N-[N-(N2-L-α-Aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-isoleucyl]-L-histidyl]-L-prolyl]-L-phenylalanine,[Ile5]-Ang II,[Ile5]-Angiotensin II,5-L-Isoleucineangiotensin II,10: PN: US20130023475 SEQID: 17 unclaimed protein,10: PN: WO0212471 SEQID: 17 unclaimed sequence,113: PN: WO2008104000 TABLE: 4 unclaimed sequence,11: PN: US20030119021 SEQID: 10 unclaimed sequence,1272: PN: US20050069911 SEQID: 1272 unclaimed sequence,12: PN: US20090088553 SEQID: 86 unclaimed protein,12: PN: WO0239997 SEQID: 17 unclaimed sequence,134: PN: WO02098448 SEQID: 144 unclaimed sequence,134: PN: WO02098906 SEQID: 144 unclaimed sequence,13: PN: US20120071544 SEQID: 7 unclaimed sequence,14: PN: WO2004007538 SEQID: 13 claimed sequence,14: PN: WO2011020056 SEQID: 95 claimed protein,154: PN: WO2009126292 TABLE: 4 unclaimed sequence,17: PN: US6610497 SEQID: 17 unclaimed sequence,17: PN: US6884771 SEQID: 17 unclaimed sequence,31: PN: WO0198325 SEQID: 32 claimed protein,32: PN: US20060014212 SEQID: 32 unclaimed sequence,32: PN: WO0056345 SEQID: 32 claimed sequence,7: PN: JP2005291836 SEQID: 6 unclaimed protein,7: PN: US20040209344 SEQID: 2 unclaimed sequence,7: PN: WO03072059 SEQID: 8 unclaimed sequence,80: PN: US6017693 TABLE: 4 claimed sequence,83: PN: US20050009742 PAGE: 21 claimed sequence,85: PN: US20080213898 SEQID: 83 claimed sequence,873: PN: US20040180380 SEQID: 1272 unclaimed sequence,8: PN: WO2008138350 SEQID: 8 claimed sequence,8: PN: WO9958140 SEQID: 1 claimed protein,96: PN: WO2008058016 SEQID: 96 claimed protein,9: PN: WO2008005531 SEQID: 17 unclaimed sequence,9: PN: WO2008106043 TABLE: 6 claimed protein,Angiotensin 2,Angiotensin II,Angiotensin II (human),Angiotensin II (mouse),Angiotensin II [Ile5],Asp-Arg-Val-Tyr-Ile-His-Pro-Phe,Asp1-Ile5-angiotensin II,Human angiotensin II,Ileu5-angiotensin II,Isoleucyl5-angiotensin II
IUPAC Name (2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-4-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-guanidinopropyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid2,2,2-trifluoroacetic acid
Molecular Formula C50H71N13O12 . x(C 2HF3O2)